Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand.
In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26-27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.
Hombach
J
J
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland. hombachj@who.int
Barrett
A D
AD
Cardosa
M J
MJ
Deubel
V
V
Guzman
M
M
Kurane
I
I
Roehrig
J T
JT
Sabchareon
A
A
Kieny
M P
MP
D000914:Antibodies, Viral / Q000097:blood; D002986:Clinical Trials as Topic; D003716:Dengue Virus / Q000276:immunology; D005416:Flavivirus / Q000276:immunology*; D006801:Humans; D022321:Japanese Encephalitis Vaccines / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*; D014902:West Nile virus / Q000276:immunology; D022341:Yellow Fever Vaccine / Q000276:immunology
D000914:Antibodies, Viral; D022321:Japanese Encephalitis Vaccines; D014765:Viral Vaccines; D022341:Yellow Fever Vaccine